Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients

Background Vaspin is a compensatory adipokine with anti-inflammatory properties that can improve insulin sensitivity and plays a cardioprotective role. Aim The aim of this study was to evaluate the level of vaspin in patients with end-stage renal disease on hemodialysis (HD) and to determine whether...

Full description

Bibliographic Details
Main Authors: Hayam H Mansour, Amal H Ibrahim, Nagwa A Mohamed, Omaima M Ali, Sherif A Nassib
Format: Article
Language:English
Published: SpringerOpen 2018-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2018;volume=30;issue=1;spage=18;epage=22;aulast=Mansour
_version_ 1828403081674489856
author Hayam H Mansour
Amal H Ibrahim
Nagwa A Mohamed
Omaima M Ali
Sherif A Nassib
author_facet Hayam H Mansour
Amal H Ibrahim
Nagwa A Mohamed
Omaima M Ali
Sherif A Nassib
author_sort Hayam H Mansour
collection DOAJ
description Background Vaspin is a compensatory adipokine with anti-inflammatory properties that can improve insulin sensitivity and plays a cardioprotective role. Aim The aim of this study was to evaluate the level of vaspin in patients with end-stage renal disease on hemodialysis (HD) and to determine whether it has any relation to the presence of ischemic heart disease (IHD) in these patients. Patients and methods The study was carried out on 45 HD patients who were divided into 15 patients with risk factors of developing IHD (group I) and 30 patients (group II) proved to have IHD by echocardiography and ECG compared with 20 healthy individuals (group III). Results We found that the mean±SD of serum vaspin was significantly lower in HD patients with IHD (0.57±0.27) ng/ml compared with the control group (0.74±0.20) ng/ml and there was a negative correlation between serum vaspin and serum creatinine in group I and group II. Also, an receiver operating characteristics study for patients with IHD (group II) yielded a vaspin cut-off value of 0.410 ng/ml with a sensitivity of 40%, a specificity of 100%, a positive predictive value of 100%, and an negative predictive value of 53%, whereas the cut-off value for serum vaspin was 0.485 ng/ml in patients at risk of developing IHD, with a sensitivity of 100%, a specificity of 85%, a positive predictive value of 83%, and an negative predictive value of 100%. Conclusion Lower vaspin level is associated independently with IHD in HD patients and can be used as a predictor of IHD in patients with end-stage renal disease.
first_indexed 2024-12-10T10:11:51Z
format Article
id doaj.art-d662c5e9f85540a3afe306ec785c26a6
institution Directory Open Access Journal
issn 1110-7782
2090-9098
language English
last_indexed 2024-12-10T10:11:51Z
publishDate 2018-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-d662c5e9f85540a3afe306ec785c26a62022-12-22T01:53:06ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982018-01-01301182210.4103/ejim.ejim_55_17Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patientsHayam H MansourAmal H IbrahimNagwa A MohamedOmaima M AliSherif A NassibBackground Vaspin is a compensatory adipokine with anti-inflammatory properties that can improve insulin sensitivity and plays a cardioprotective role. Aim The aim of this study was to evaluate the level of vaspin in patients with end-stage renal disease on hemodialysis (HD) and to determine whether it has any relation to the presence of ischemic heart disease (IHD) in these patients. Patients and methods The study was carried out on 45 HD patients who were divided into 15 patients with risk factors of developing IHD (group I) and 30 patients (group II) proved to have IHD by echocardiography and ECG compared with 20 healthy individuals (group III). Results We found that the mean±SD of serum vaspin was significantly lower in HD patients with IHD (0.57±0.27) ng/ml compared with the control group (0.74±0.20) ng/ml and there was a negative correlation between serum vaspin and serum creatinine in group I and group II. Also, an receiver operating characteristics study for patients with IHD (group II) yielded a vaspin cut-off value of 0.410 ng/ml with a sensitivity of 40%, a specificity of 100%, a positive predictive value of 100%, and an negative predictive value of 53%, whereas the cut-off value for serum vaspin was 0.485 ng/ml in patients at risk of developing IHD, with a sensitivity of 100%, a specificity of 85%, a positive predictive value of 83%, and an negative predictive value of 100%. Conclusion Lower vaspin level is associated independently with IHD in HD patients and can be used as a predictor of IHD in patients with end-stage renal disease.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2018;volume=30;issue=1;spage=18;epage=22;aulast=Mansourhemodialysisischemic heart diseaseserum vaspin level
spellingShingle Hayam H Mansour
Amal H Ibrahim
Nagwa A Mohamed
Omaima M Ali
Sherif A Nassib
Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients
The Egyptian Journal of Internal Medicine
hemodialysis
ischemic heart disease
serum vaspin level
title Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients
title_full Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients
title_fullStr Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients
title_full_unstemmed Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients
title_short Serum vaspin: as a predictor of ischemic heart disease in Egyptian hemodialysis patients
title_sort serum vaspin as a predictor of ischemic heart disease in egyptian hemodialysis patients
topic hemodialysis
ischemic heart disease
serum vaspin level
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2018;volume=30;issue=1;spage=18;epage=22;aulast=Mansour
work_keys_str_mv AT hayamhmansour serumvaspinasapredictorofischemicheartdiseaseinegyptianhemodialysispatients
AT amalhibrahim serumvaspinasapredictorofischemicheartdiseaseinegyptianhemodialysispatients
AT nagwaamohamed serumvaspinasapredictorofischemicheartdiseaseinegyptianhemodialysispatients
AT omaimamali serumvaspinasapredictorofischemicheartdiseaseinegyptianhemodialysispatients
AT sherifanassib serumvaspinasapredictorofischemicheartdiseaseinegyptianhemodialysispatients